Bisphosphonates are a class of medications that slow down bone loss by targeting the cells responsible for breaking down old bone. They are the most widely prescribed treatment for osteoporosis and can reduce the risk of spinal fractures by 60 to 70% within the first year of use. They’re also used to treat other conditions where bone is being lost or destroyed too quickly.
How Bisphosphonates Work Inside Your Bones
Your skeleton is constantly remodeling itself. Specialized cells called osteoclasts dissolve old bone, while other cells called osteoblasts build new bone in its place. In osteoporosis and similar conditions, the balance tips toward too much breakdown and not enough rebuilding. Bisphosphonates correct this by going after the osteoclasts.
Once you take a bisphosphonate, the drug travels through your bloodstream and binds directly to the surface of your bones, particularly in areas where bone is actively being broken down. When osteoclasts try to dissolve bone that contains the drug, the released bisphosphonate disrupts them in several ways: it prevents them from attaching properly to the bone surface, blocks the chemical reactions they need to dissolve bone tissue, and ultimately triggers the osteoclasts to self-destruct. The drug also reduces the number of new osteoclasts your body produces in the first place.
The result is that bone breakdown slows dramatically while bone building continues at a more normal pace. Over time, this tips the balance back toward stronger, denser bones.
What Conditions They Treat
Osteoporosis is the most common reason bisphosphonates are prescribed, but they have several other uses. In Paget’s disease, a condition where bones grow abnormally large and weak, bisphosphonates help regulate the overactive bone remodeling cycle. They’re also used to manage dangerously high blood calcium levels (hypercalcemia), which can occur in certain cancers. In cancer care more broadly, bisphosphonates help protect bones when tumors have spread to the skeleton or when hormone-blocking cancer treatments accelerate bone loss.
How Much They Strengthen Bone
A meta-analysis of studies in older women with low bone density found that bisphosphonates increased bone mineral density at the lumbar spine by about 5.6%, at the hip by about 4.8%, and at the femoral neck by about 4%, compared to a placebo. These gains were measured across studies lasting one to six years. While those percentages may sound modest, they translate into meaningful fracture protection.
For spinal fractures, bisphosphonates reduce risk by 60 to 70%. Hip fracture risk drops by 40 to 50%, and the risk of other non-spinal fractures falls by 20 to 30%. These reductions apply to the most commonly used bisphosphonates, with one exception: ibandronate has not demonstrated the same protection against hip and non-spinal fractures.
Common Bisphosphonate Medications
Bisphosphonates come in both pill and IV (infusion) forms. The oral options available in the United States include alendronate, risedronate, and ibandronate. Alendronate is the most commonly prescribed and is typically taken once a week. Risedronate can be taken weekly or monthly depending on the formulation. Ibandronate is taken once a month as a pill or can be given as an infusion.
IV bisphosphonates include zoledronic acid and pamidronate. Zoledronic acid is particularly convenient for osteoporosis because it’s given as a single infusion once a year. Pamidronate, given through a drip, is more commonly used in cancer-related bone conditions and Paget’s disease.
How to Take Oral Bisphosphonates
Oral bisphosphonates are notoriously finicky about how you take them. The drug is poorly absorbed under the best circumstances, and food or other beverages interfere with absorption significantly. You need to swallow the tablet whole with at least 200 ml (about a full glass) of plain water, first thing in the morning on a completely empty stomach. After taking it, stay fully upright, either standing or sitting, for at least 30 minutes. During that time, don’t eat, drink anything else, or take other medications.
These instructions aren’t optional. Lying down or eating too soon can cause the tablet to irritate or damage your esophagus, and taking it with food can reduce absorption to nearly zero. If this routine feels difficult to maintain, an IV bisphosphonate given once a year or every few months may be a better fit.
Side Effects and Rare Risks
The most common side effects of oral bisphosphonates involve the digestive system: heartburn, nausea, stomach pain, and irritation of the esophagus. These are largely preventable by following the dosing instructions carefully. IV bisphosphonates can cause flu-like symptoms (fever, muscle aches, fatigue) for a day or two after the infusion, especially the first time.
Two rare but serious complications get the most attention. Osteonecrosis of the jaw is a condition where a section of jawbone loses its blood supply and begins to deteriorate. In people taking bisphosphonates for osteoporosis, this is extremely uncommon, with estimates ranging from 1 in 10,000 to 1 in 250,000 patients. The risk is considerably higher in cancer patients receiving much larger IV doses. Dental work, particularly tooth extractions, appears to be a triggering factor, so many doctors recommend completing any major dental procedures before starting treatment.
Atypical femur fractures are unusual breaks that occur in the thigh bone, often with minimal trauma. The absolute risk is low, ranging from about 3 to 50 cases per 100,000 person-years of use, but it increases with longer treatment duration. This is one of the main reasons doctors recommend periodic breaks from the medication.
Treatment Duration and Drug Holidays
Bisphosphonates aren’t meant to be taken indefinitely. Because the drug accumulates in bone and continues working even after you stop taking it, most guidelines recommend a planned break after a set period. For oral bisphosphonates like alendronate, risedronate, and ibandronate, this is typically after five years. For zoledronic acid infusions, a break is considered after three years.
During the drug holiday, the bisphosphonate stored in your bones continues to provide some protection. The recommended length of the break depends on the specific medication. For alendronate, the break is usually about two years. For risedronate and ibandronate, it’s about one year. For zoledronic acid, the holiday lasts about three years before reassessment.
Not everyone is a good candidate for a drug holiday. If you’re over 75, have already broken a hip or spinal bone, or are taking high-dose steroids, your fracture risk may be too high to safely pause treatment. After 10 years of continuous use without breaks, there’s limited evidence to guide decisions, and specialist review is generally recommended to weigh the ongoing benefits against the accumulating risk of rare side effects.